CLINICAL_TRIALS
trial_result
· 2016-03-07
Clinical Trial Update: Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury [Phase 2]
Summary
Phase 2 study evaluating safety and pharmacokinetics of VAS203 in patients with Traumatic Brain Injury has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: veriNOS operations GmbH | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED | Results posted: 2016-03-07